130 related articles for article (PubMed ID: 15113063)
1. Health economic evaluation of liver MRI in colorectal cancer patients.
Helmberger T; Annemans L; Warie H; Müller U
Eur Radiol; 2004 Jan; 14 Suppl 1():C13. PubMed ID: 15113063
[No Abstract] [Full Text] [Related]
2. Health economic evaluation of ferucarbotran-enhanced MRI in the diagnosis of liver metastases in colorectal cancer patients.
Annemans L; Lencioni R; Warie H; Bartolozzi C; Ciceri M; Müller U
Int J Colorectal Dis; 2008 Jan; 23(1):77-83. PubMed ID: 17912536
[TBL] [Abstract][Full Text] [Related]
3. [Obsolete methods in examination of the liver with MRI].
Schadmand-Fischer S
Rofo; 1998 Dec; 169(6):679-80. PubMed ID: 9930229
[No Abstract] [Full Text] [Related]
4. Accumulation of iron oxide particles around liver metastases during MR imaging.
Hahn PF; Stark DD; Ferrucci JT
Gastrointest Radiol; 1992; 17(2):173-4. PubMed ID: 1551515
[TBL] [Abstract][Full Text] [Related]
5. [Detection of liver tumors].
Rummeny EJ; Reimer P; Daldrup H; Peters PE
Radiologe; 1995 Nov; 35(11 Suppl 2):S252-8. PubMed ID: 8588031
[TBL] [Abstract][Full Text] [Related]
6. Ferumoxide-enhanced magnetic resonance imaging techniques in pre-operative assessment for colorectal liver metastases.
van Etten B; van der Sijp J; Kruyt R; Oudkerk M; van der Holt B; Wiggers T
Eur J Surg Oncol; 2002 Sep; 28(6):645-51. PubMed ID: 12359202
[TBL] [Abstract][Full Text] [Related]
7. Advantages and differences of Resovist towards Gadolinium contrast in MRI with focus on metastatic liver lesions.
Reimer P; Balzer T
Eur Radiol; 2004 Jan; 14 Suppl 1():C4. PubMed ID: 15113058
[No Abstract] [Full Text] [Related]
8. Imaging of small hepatic metastases of colorectal carcinoma: how to use superparamagnetic iron oxide-enhanced magnetic resonance imaging in the multidetector-row computed tomography age?
Motosugi U; Ichikawa T; Nakajima H; Sou H; Sano M; Sano K; Araki T; Iino H; Fujii H; Nakazawa T
J Comput Assist Tomogr; 2009; 33(2):266-72. PubMed ID: 19346857
[TBL] [Abstract][Full Text] [Related]
9. SPIO-MRI in the detection of hepatocellular carcinoma.
Araki T
J Gastroenterol; 2000; 35(11):874-6. PubMed ID: 11085500
[No Abstract] [Full Text] [Related]
10. Radiofrequency ablation of colorectal liver metastases in a transplanted liver.
Chin K; Mangat K
Cardiovasc Intervent Radiol; 2009 Sep; 32(5):1114-6. PubMed ID: 19504153
[No Abstract] [Full Text] [Related]
11. Experience with Resovist in gastroenterologic radiology and intervention.
Vogl TJ; Schwarz W; Marquart F; Parmentier S; Götz B; Thalhammer A; Hammerstingl R
Eur Radiol; 2004 Jan; 14 Suppl 1():C7-9. PubMed ID: 15113060
[No Abstract] [Full Text] [Related]
12. Results of a multicenter phase II clinical trial with a susceptibility contrast medium for magnetic resonance imaging of the liver.
Balzer T; Carter EC; Shamsi K; Niendorf HP
Acad Radiol; 1996 Aug; 3 Suppl 2():S417-9. PubMed ID: 8796619
[No Abstract] [Full Text] [Related]
13. [Detection of liver lesions: magnetic resonance tomography using superparamagnetic iron particles (AMI-25, endorem) as a contrast medium in comparison with ultrasound diagnosis, computerized tomography and CT portography].
Pleger B; Beyer HK; Laufer U
Rontgenpraxis; 2001; 53(6):245-9. PubMed ID: 11402872
[No Abstract] [Full Text] [Related]
14. Will ferumoxides-enhanced MR imaging replace CT during arterial portography in the detection of hepatic metastases? Prologue to a promising future.
Soyer P
Radiology; 1996 Sep; 200(3):610-1. PubMed ID: 8756902
[No Abstract] [Full Text] [Related]
15. Preoperative patient work-up: Resovist-enhanced MRI vs. multislice CT--preliminary results of an ongoing study.
Heinz-Peer G
Eur Radiol; 2004 Jan; 14 Suppl 1():C11-2. PubMed ID: 15113062
[No Abstract] [Full Text] [Related]
16. Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients.
Kim HJ; Kim KW; Byun JH; Won HJ; Shin YM; Kim PN; Lee MS; Lee MG
AJR Am J Roentgenol; 2006 Apr; 186(4):1059-66. PubMed ID: 16554579
[TBL] [Abstract][Full Text] [Related]
17. Effects of superparamagnetic iron oxide (AMI-25) on liver and spleen imaging using spin-echo and fast spin-echo magnetic resonance pulse sequences.
Schwartz LH; Seltzer SE; Adams DF; Tempany CM; Piwnica-Worms DR; Silverman SG; Herman L; Herman LT; Hooshmand R
Invest Radiol; 1994 Jun; 29 Suppl 2():S21-3. PubMed ID: 7928234
[No Abstract] [Full Text] [Related]
18. MR enhancement of hepatoma by superparamagnetic iron oxide (SPIO) particles.
Yamamoto H; Yamashita Y; Yoshimatsu S; Baba Y; Takahashi M
J Comput Assist Tomogr; 1995; 19(4):665-7. PubMed ID: 7622710
[No Abstract] [Full Text] [Related]
19. European clinical experience with Endorem. A new contrast agent for liver MRI in 1000 patients.
Chachuat A; Bonnemain B
Radiologe; 1995 Nov; 35(11 Suppl 2):S274-6. PubMed ID: 8588035
[No Abstract] [Full Text] [Related]
20. Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US.
Hagspiel KD; Neidl KF; Eichenberger AC; Weder W; Marincek B
Radiology; 1995 Aug; 196(2):471-8. PubMed ID: 7617863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
